Ignite Creation Date:
2024-10-25 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06504628
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-10
Brief Title:
Falls Among the Older Patients Treated for Cancer in Normandys Outclinics Screening and Prevention
Sponsor:
None
Organization:
None
Study Overview
Official Title:
CHUtes Chez Les Personnes Agées traitées Pour Cancer Dans Les HOpitaUx Normands repérage et Prévention
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CHUPACHOUP
Brief Summary:
The French Plan National AntiChute published on February 21 2022 and international recommendations on falls prevention Age AgeingSeptember 2022 recommend identifying the risk of falling in people aged 65 and over at least once a year during a follow-up consultation The presence of chronic illness such as cancer increases the risk for falling Recommendations suggest targeted preventive interventions according to the risk level and early reassessment at 3 months in case of high risk
This study consists of a cross-sectional survey conducted during a week dedicated to patient safety September 16-20 2024 to identify the prevalence of patients at high risk for falling requiring enhanced care The relation between high risk for falling and social and oncological characteristics will be studied A 3-month telephone follow-up will identify any obstacles to implementing the recommendations in this high-risk group
This multicenter cross-sectional prospective study is exploratory
This study consists of a cross-sectional survey conducted during a week dedicated to patient safety September 16-20 2024 to identify the prevalence of patients at high risk for falling requiring enhanced care The relation between high risk for falling and social and oncological characteristics will be studied A 3-month telephone follow-up will identify any obstacles to implementing the recommendations in this high-risk group
This multicenter cross-sectional prospective study is exploratory
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None